Skip to main content
Clinical Trials/NL-OMON51872
NL-OMON51872
Recruiting
Not Applicable

The value of a risk prediction tool (PERSARC) for effectvie treatment decision making: a stepped wedge Randomized Controlled Trial. - VALUE-PERSARC

eids Universitair Medisch Centrum0 sites120 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
soft tissue extremity sarcomas
Sponsor
eids Universitair Medisch Centrum
Enrollment
120
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients \>\= 18 years
  • Histologically diagnosed with grade 2\-3 STS in their extremities.
  • Who do not have a treatment plan yet
  • Dutch fluency and literacy
  • Mentally competent
  • Signed informed consent
  • \- Patient owns smartphone with internet access (WiFi)

Exclusion Criteria

  • Patient that are treated without curative intent
  • Patient that needs to be treated with chemotherapy or isolated limb perfusion
  • Patients were surgery is not indicated
  • Sarcoma subtypes not mentioned in the PERSARC app
  • In summary: patients with sarcoma subtypes and/or patients that need to be
  • treated with other treatment modalities than those mentioned in the PERSARC app
  • are excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials